Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DSP-1083 by Sumitomo Pharma for Parkinson's Disease: Likelihood of Approval
DSP-1083 is under clinical development by Sumitomo Pharma and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...